BLKB vs DBD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
BLKB
DBD
Investment Advisor Scores
DBD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BLKB | DBD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.6687 | 12.1655 | BLKB |
| PEG Ratio | 0.4537 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 3.0% | 1.7% | BLKB |
| Earnings Growth | 43.6% | 34.2% | BLKB |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.1/100 | 36.2/100 | BLKB |
| Profit Margin | 13.1% | 2.9% | BLKB |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | AVOID NEW MONEY | BLKB |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BLKB
MarkupPrice above SMA50, rising 50-day trend (7.1% over 20 days), RSI 84
DBD
NeutralMixed signals - no dominant trend phase, RSI 62
Fundamentals Snapshot
| Metric | BLKB | DBD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.0 | 9.7 |
| Trailing P/E | 16.7 | 22.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.6% | 0.3% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 3.20 | 3.03 |
| Dividend Yield | — | — |